FDA — authorised 11 March 2005
- Application: NDA021730
- Marketing authorisation holder: LUPIN
- Status: supplemented
🇺🇸 xopenex in United States
FDA authorised xopenex on 11 March 2005
Marketing authorisations
FDA
- Status: approved
Other Respiratory approved in United States
Frequently asked questions
Is xopenex approved in United States?
Yes. FDA authorised it on 11 March 2005; FDA has authorised it.
Who is the marketing authorisation holder for xopenex in United States?
LUPIN holds the US marketing authorisation.